These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4054202)

  • 21. Cellular and plasma kinetics of daunorubicin given by two methods of administration in a patient with acute leukemia.
    DeGregorio MW; Carrera CJ; Klock JC; Pegelow CH; Wilbur JR
    Cancer Treat Rep; 1982 Dec; 66(12):2085-8. PubMed ID: 6958366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Granulocyte function in myeloblastic leukaemia.
    Wilkinson PM; Sumner C; Delamore IW; Geary CG; Milner GR
    Br J Cancer; 1975 Nov; 32(5):574-7. PubMed ID: 764849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immobilized forms of daunorubicin in patients with acute leukemia].
    Isaev VG; Garmaeva TTs; Skorokhod AA; Parovichnikova EN; Tiurina NG; Kucher RA; Vitvitskiĭ VM; Ataullakhanov FI; Savchenko VG
    Ter Arkh; 1999; 71(10):32-7. PubMed ID: 10612171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood.
    Kaspers GJ; Pieters R; Van Zantwijk CH; De Laat PA; De Waal FC; Van Wering ER; Veerman AJ
    Br J Cancer; 1991 Sep; 64(3):469-74. PubMed ID: 1911186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The interaction of daunomycin with normal and leukaemic leukocyte DNA.
    Gray PJ; Phillips DR
    Eur J Cancer (1965); 1976 Mar; 12(3):237-8. PubMed ID: 939241
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical pharmacology of daunorubicin in patients with acute leukemia.
    Riggs CE
    Semin Oncol; 1984 Dec; 11(4 Suppl 3):2-11. PubMed ID: 6390687
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of verapamil on the cellular accumulation of daunorubicin in blast cells and on the chemosensitivity of leukaemic blast progenitors in acute myelogenous leukaemia.
    Maruyama Y; Murohashi I; Nara N; Aoki N
    Br J Haematol; 1989 Jul; 72(3):357-62. PubMed ID: 2765404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P-Glycoprotein inhibitor valspodar (PSC 833) increases the intracellular concentrations of daunorubicin in vivo in patients with P-glycoprotein-positive acute myeloid leukemia.
    Tidefelt U; Liliemark J; Gruber A; Liliemark E; Sundman-Engberg B; Juliusson G; Stenke L; Elmhorn-Rosenborg A; Möllgård L; Lehman S; Xu D; Covelli A; Gustavsson B; Paul C
    J Clin Oncol; 2000 May; 18(9):1837-44. PubMed ID: 10784624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia.
    Pea F; Russo D; Michieli M; Baraldo M; Ermacora A; Damiani D; Baccarani M; Furlanut M
    Cancer Chemother Pharmacol; 2000; 46(4):279-86. PubMed ID: 11052625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of the cellular uptake of daunorubicin in human leukemia in vivo: method of examination and first results.
    Scheulen ME; Lennartz K; Heidrich T; Host G; Kramer B
    Haematol Blood Transfus; 1987; 30():298-301. PubMed ID: 3476361
    [No Abstract]   [Full Text] [Related]  

  • 31. Higher plasma but not intracellular concentrations after infusion with liposomal daunorubicin compared with conventional daunorubicin in adult acute myeloid leukemia.
    Löfgren C; Lehmann S; Jönsson-Videsäter K; Möllgård L; Linder O; Tidefelt U; Hassan M; Paul C
    Ther Drug Monit; 2007 Oct; 29(5):626-31. PubMed ID: 17898654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional multidrug resistance in acute myeloblastic leukaemia: a standardized flow cytometric assay for intracellular daunorubicin accumulation.
    Pallis M; Russell NH
    Br J Haematol; 1998 Jan; 100(1):194-7. PubMed ID: 9450811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liquid chromatographic monitoring of daunorubicin and daunorubicinol in plasma from leukemic patients treated with daunorubicin or the daunorubicin-DNA complex.
    Andersson B; Andersson I; Beran M; Ehrsson H; Eksborg S
    Cancer Chemother Pharmacol; 1979; 2(1):15-7. PubMed ID: 498413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vivo concentrations of an antimitotic, daunorubicin, in peripheral and bone marrow human leukemia cells].
    Faucon G; Trillet V; Lang J; Lakhal M; Timour Chah Q
    Bull Acad Natl Med; 1985 Oct; 169(7):1045-52. PubMed ID: 3914322
    [No Abstract]   [Full Text] [Related]  

  • 35. Significance of cellular pharmacokinetics for the cytotoxic effects of daunorubicin.
    Andersson B; Beran M; Peterson C; Tribukait B
    Cancer Res; 1982 Jan; 42(1):178-83. PubMed ID: 7053847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative uptake, retention and cytotoxicity of daunorubicin by human myeloid cells.
    Vasanthakumar G; Ahmed NK
    Biochem Pharmacol; 1986 Apr; 35(7):1185-90. PubMed ID: 3457568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Motility of leukaemic cells in acute leukaemia related to tumour mass, maturation and FAB classification.
    van der Weide M; Imandt LM; Langenhuijsen MM
    Acta Haematol; 1988; 80(1):34-9. PubMed ID: 3135690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukemic cell and plasma daunomycin concentrations after bolus injection and 72 h infusion.
    Speth PA; Linssen PC; Boezeman JB; Wessels HM; Haanen C
    Cancer Chemother Pharmacol; 1987; 20(4):311-5. PubMed ID: 3690804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liposomal encapsulation of a synergistic molar ratio of cytarabine and daunorubicin enhances selective toxicity for acute myeloid leukemia progenitors as compared to analogous normal hematopoietic cells.
    Kim HP; Gerhard B; Harasym TO; Mayer LD; Hogge DE
    Exp Hematol; 2011 Jul; 39(7):741-50. PubMed ID: 21530609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P-glycoprotein (PGP) and lung resistance-related protein (LRP) expression and function in leukaemic blast cells.
    Michieli M; Damiani D; Ermacora A; Raspadori D; Michelutti A; Grimaz S; Fanin R; Russo D; Lauria F; Masolini P; Baccarani M
    Br J Haematol; 1997 Feb; 96(2):356-65. PubMed ID: 9029025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.